Since previous data hint that ANXA6 acts as an oncogene to aggravate malignancy in BC, we investigated whether PR-BC-exo affected the malignant phenotypes, including cell mobility, growth, and stemness in BC cells. Here, ANXA6 is linked to breast cancer.